These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3396787)

  • 1. Pharmacological studies on the in vivo cataractogenicity of acetaminophen in mice and rabbits.
    Lubek BM; Avaria M; Basu PK; Wells PG
    Fundam Appl Toxicol; 1988 May; 10(4):596-606. PubMed ID: 3396787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic evidence for the involvement of enzymatic bioactivation in the cataractogenicity of acetaminophen in genetically susceptible (C57BL/6) and resistant (DBA/2) murine strains.
    Lubek BM; Basu PK; Wells PG
    Toxicol Appl Pharmacol; 1988 Jul; 94(3):487-95. PubMed ID: 3400097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo murine studies on the biochemical mechanism of acetaminophen cataractogenicity.
    Wells PG; Wilson B; Winn LM; Lubek BM
    Can J Physiol Pharmacol; 1995 Aug; 73(8):1123-9. PubMed ID: 8564879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo murine studies on the biochemical mechanism of naphthalene cataractogenesis.
    Wells PG; Wilson B; Lubek BM
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):466-73. PubMed ID: 2749733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic modulation of acetaminophen bioactivation and hepatotoxicity by pretreatment with the interferon inducer polyinosinic-polycytidylic acid.
    Kalabis GM; Wells PG
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1408-19. PubMed ID: 2262910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro hepatotoxicity and metabolism of acetaminophen in Syrian hamsters.
    Lupo S; Yodis LA; Mico BA; Rush GF
    Toxicology; 1987 May; 44(2):229-39. PubMed ID: 3564056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ah locus: genetic differences in susceptibility to cataracts induced by acetaminophen.
    Shichi H; Gaasterland DE; Jensen NM; Nebert DW
    Science; 1978 May; 200(4341):539-41. PubMed ID: 644313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine acetaminophen hepatotoxicity: temporal interanimal variability in plasma glutamic-pyruvic transaminase profiles and relation to in vivo chemical covalent binding.
    Wells PG; To EC
    Fundam Appl Toxicol; 1986 Jul; 7(1):17-25. PubMed ID: 3732668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction.
    Gregus Z; Madhu C; Klaassen CD
    Drug Metab Dispos; 1990; 18(1):10-9. PubMed ID: 1970767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histocytological study on the possible mechanism of acetaminophen cataractogenesis in mouse eye.
    Zhao C; Shichi H
    Exp Mol Pathol; 1995 Oct; 63(2):118-28. PubMed ID: 8941046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed enhancement of acetaminophen hepatotoxicity by general anesthesia using diethyl ether or halothane.
    Wells PG; Ramji P; Ku MS
    Fundam Appl Toxicol; 1986 Feb; 6(2):299-306. PubMed ID: 3699320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the hepatotoxic effect of acetaminophen by prior administration of salicylate.
    Douidar SM; Boor PJ; Ahmed AE
    J Pharmacol Exp Ther; 1985 Apr; 233(1):242-8. PubMed ID: 3981458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cataractogenicity and bioactivation of naphthalene derivatives in lens culture and in vivo.
    Lubek BM; Kubow S; Basu PK; Wells PG
    Lens Eye Toxic Res; 1989; 6(1-2):203-9. PubMed ID: 2562167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of acetaminophen- and naphthalene-induced cataract and glutathione loss by CySSME.
    Rathbun WB; Holleschau AM; Cohen JF; Nagasawa HT
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):923-9. PubMed ID: 8603877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and induction sites of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 in murine liver: immunohistochemical localization with monoclonal antibodies.
    Forkert PG; Mirehouse-Brown P; Park SS; Gelboin HV
    Mol Pharmacol; 1988 Dec; 34(6):736-43. PubMed ID: 2462160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methylcholanthrene to the Ah receptor in hepatic cytosols from phenobarbital-treated rats and mice.
    Okey AB; Vella LM
    Biochem Pharmacol; 1984 Feb; 33(4):531-8. PubMed ID: 6322806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of subacute dosing and phenobarbital and 3-methylcholanthrene pretreatment on the metabolism of acetaminophen in rats.
    Thomas BH; Zeitz W; Beaubien AR
    Can J Physiol Pharmacol; 1977 Feb; 55(1):77-83. PubMed ID: 843994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of transplacental tumorigenesis by 3-methylcholanthrene in mice by genotype at the Ah locus and pretreatment with beta-naphthoflavone.
    Anderson LM; Jones AB; Riggs CW; Kovatch RM
    Cancer Res; 1989 Apr; 49(7):1676-81. PubMed ID: 2538231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of caffeine with acetaminophen. 1. Correlation of the effect of caffeine on acetaminophen hepatotoxicity and acetaminophen bioactivation following treatment of mice with various cytochrome P450 inducing agents.
    Jaw S; Jeffery EH
    Biochem Pharmacol; 1993 Aug; 46(3):493-501. PubMed ID: 8347173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of acetaminophen-induced cataract by a combination of diallyl disulfide and N-acetylcysteine.
    Zhao C; Shichi H
    J Ocul Pharmacol Ther; 1998 Aug; 14(4):345-55. PubMed ID: 9715438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.